On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from Kenneth Steiner, on the adoption of a Board policy that the Chairperson of the Board be an independent director was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.79 USD | +0.05% | +3.19% | -18.57% |
03:31pm | Bristol-Myers Squibb Says Opdivo Plus Yervoy Therapy Improves Survival of Liver Cancer Patients | MT |
02:38pm | Bristol Myers: positive results in liver cancer | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.57% | 84.67B | |
+42.01% | 748B | |
+34.11% | 598B | |
-6.59% | 356B | |
+18.16% | 325B | |
+4.02% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+1.93% | 166B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company